Revance 2.0: The Next Chapter in Aesthetic Innovation — Nadeem Moiz

This week, Dr. Randi @drrandishow sits down with Nadeem Moiz, CEO of Revance, for a rare, unfiltered look at how one of aesthetics’ most-watched companies is rewriting its playbook. From the rapid rise of Daxxify to the next generation of RHA® fillers, SkinPen®, and regenerative innovations, Moiz reveals how Revance is building something bigger than products- a connected ecosystem that meets today’s more informed, self-aware patient.

He shares where Revance is doubling down, from science-backed longevity and stackable protocols, to AI-powered insight that’s changing how patients experience care. It’s a story of precision, evolution, and the kind of leadership that doesn’t chase trends, it defines them.

In this episode:

🔹The Daxxify effect: How a performance-driven neurotoxin is reshaping patient expectations and market momentum

🔹RHA® with mepivacaine: The subtle advancement improving comfort and precision for every injector

🔹Regenerative rise: SkinPen®, PRP, and biologic stacks driving the skin health revolution

🔹Stackable strategies: Smarter, synergistic treatment combinations that deliver real-world results

🔹The GLP-1 era: Where fillers, biostimulators, and skin rejuvenation fit as body composition shifts

🔹AI with purpose: How data is powering everything from R&D to patient journeys

🔹2026 preview: A look at where regenerative science, and Revance, are headed next

It’s the kind of conversation that doesn’t just reflect the future of aesthetics, it helps define it.